SUMMARYWe report a single center experience of surgical treatment of 30 cases of left-sided prosthetic valve thrombosis (PVT). In our series, a diagnosis of PVT was established based on clinical and echocardiographic examinations. Thrombosis was the major etiologic factor in 25 patients (83.3%), while 22 of 25 patients (88%) had a subtherapeutic anticoagulation level. The early hospital mortality rate was 7.1% in patients with New York Heart Association (NYHA) functional classes II -III, and 31.3% in NYHA functional class IV. The median interval from the surgical procedure to follow-up for these patients was 29. Prosthetic valve thrombosis (PVT) is a rare but life-threatening condition. The incidence of PVT ranges from 0.03 to 4.3% patient-years, depending on the generation and the biocompabilities of the prosthesis used, the location of the valve, and inadequate or discontinued anticoagulation therapy.1, 2) Surgical mortality increases from 2% to 4% in low-risk groups to 37% to 54% in high-risk groups. [3][4][5] We report a single center experience of surgical treatment of 30 cases of leftsided PVT in order to better analyze the factors influencing success, determining operative mortality, and long-term survival.From the